Clinical Trials on Influenza With Pneumonia in France

Total 1965 results

Radboud University Medical Center

Recruiting

Prospective Observational Trial of IAPA (IAPAFLU)

Pulmonary Aspergillosis | Influenza With Pneumonia

Belgium, France, Netherlands
Central Hospital, Nancy, France

Unknown

Epidemiology of Post-influenza Bacterial Pneumonia Due to a Panton-Valentine Leukocidin Positive Staphylococcus Aureus (FLUVALENTINE)

Influenza | Staphylococcus Aureus Pneumonia | PV Leukocidin

France
Hospices Civils de Lyon

Completed

Effect of Influenza Vaccination of Healthcare Workers (HCW) on the Risk of Influenza in Patients Hospitalized in Short Stays Units

Patient With Influenza Like Illness

France
University of Versailles
Assistance Publique - Hôpitaux de Paris

Terminated

Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu (CORTIFLU)

Pneumonia, Viral | Influenza in Humans

France
University Hospital, Caen

Not yet recruiting

An Antibiotic Protocol Guided by a Multimodal Approach in AECOPD With Pneumonia in Intensive Care (BPCTréa2)

To Reduce Duration of Antibiotics Exposure in Patients With COPD Hospitalized in Intensive Care Unit With Pneumonia

France
University Hospital, Bordeaux

Completed

Interest of Ascorbic Acid in the Management of Pneumonia in Elderly People Hospitalized. (PNEUMO-VITA-C)

Pneumonia With Hospitalized Elderly Patient

France
Institut National de la Santé Et de la Recherche...

Completed

Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study (RESPIFLU)

Quality of Life | Pneumonia, Viral | Pulmonary Fibrosis | Influenza | Stress Disorders, Post Traumatic

France
Assistance Publique - Hôpitaux de Paris

Completed

RAPid SOlution for Diagnosis of Respiratory Infection in Pediatric Intensive Care Unit (RAPSODI)

Severe Infections Pneumonia With Invasive Ventilation in PICU

France
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media

Pneumococcal Infections | Otitis Media | Otitis Media With Effusion

France
Hospices Civils de Lyon

Completed

Panton Valentine Leucocidin (PVL)

Staphylococcus Aureus Pneumonias

France
Institut National de la Santé Et de la Recherche...

Unknown

Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff. (FLU-HOP)

Influenza A Virus, H1N1 Subtype

France
Assistance Publique - Hôpitaux de Paris
Groupe Hospitalier Pitie-Salpetriere

Terminated

ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic (ACORES-2)

History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 Infection

France
BioNTech SE
Pfizer

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza

COVID-19 | Influenza, Human

United States
Department of Clinical Research and Innovation

Unknown

Streptococcus Pneumoniae Nasopharyngeal Carriage

Nursery

France
Assistance Publique - Hôpitaux de Paris
GlaxoSmithKline; Hoffmann-La Roche

Terminated

Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir (BIVIR)

Gastric Influenza

France
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Early Oseltamivir Carboxylate Low Plasma Concentration in Patients Admitted to Intensive Care for Severe Influenza (OPTIFLU)

Severe Influenza

France
Assistance Publique - Hôpitaux de Paris
Orakine Ltd, Dublin, Ireland

Terminated

Effect of the Interferon Alpha Citizen by Sub-Lingual Way on the Humoral Immunizing Answer (GP-INFA)

Influenza Infection

France
Centre Hospitalier Universitaire Dijon

Completed

Identification and Quantification of Immune Response Induced by Hyaluronidase and Other Factors of Virulence of Invasive Human Infections of Streptococcus Pneumoniae (Hyalo strepto)

Invasive Pneumococcic

France
Assistance Publique - Hôpitaux de Paris

Terminated

Influenza Vaccination of Nursing Home Workers.

Influenza Disease

France
Assistance Publique - Hôpitaux de Paris

Completed

Face Masks for Preventing Influenza Transmission (GRIPMASK)

Influenza Human

France
Centre Hospitalier Universitaire Dijon

Completed

Impact of COVID-19 Infection and Confinement on Diabetic Ulcer Management and Amputation Risk (COROPIEDIAB)

Diabetic Subjects With Hospital Stays

France
Assistance Publique - Hôpitaux de Paris

Unknown

Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort. (CORIMUNO-NIVO)

COVID19- Infection With SARS-CoV-2 Virus

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Impact on Influenza Vaccination Rates of a Telephone Text Message Recall From the Attending Physician (GP-FluRecall)

Influenza Viral Infections

France
Sanofi Pasteur, a Sanofi Company

Completed

Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers

Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b

France, Poland
Central Hospital, Nancy, France

Completed

Comparison of ARDS COVID-19 (WHO) vs ARDS Influenza in the ICU

Influenza | ARDS | COVID-19 Acute Respiratory Distress Syndrome

France
Hospices Civils de Lyon

Terminated

Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection (Combina)

Influenza A Infection

France
Sanofi Pasteur, a Sanofi Company

Completed

A Study of the Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy Adults

Influenza | Swine-origin A/H1N1 Influenza

France
Centre Hospitalier Universitaire de Nīmes

Recruiting

Prevention of Pneumococcal Infections: Impact Collaborative Medico-pharmaceutical Care Structured to Improve Vaccination Coverage of Patients at Risk. (OPTIVACC)

Streptococcus Pneumoniae Infection

France
BioNTech SE
Pfizer

Recruiting

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.

COVID-19 | Influenza

United States
Central Hospital, Nancy, France

Unknown

Interstitial Pneumonia With Autoimmune Features: Evaluation of Connective Tissue Disease Incidence During Follow-up (EVOLIPAF)

Idiopathic Interstitial Pneumonia

France
Groupe Hospitalier Paris Saint Joseph

Completed

Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Versus Xpert Flu/RSV

Influenza

France
University Hospital, Montpellier

Unknown

Cognitive Remediation on Patients With Bipolar Disorder and Memory Complaints (COGMED)

Euthymic Status | Patient With Bipolar Disorder | Wirh Memory Complaints

France
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy and Safety of Influenza Vaccine During Sarcoidosis (SARCOVAC)

Influenza Vaccine | Sarcoidosis

France
CEN Biotech
Urgo Research, Innovation & Development

Recruiting

Effectiveness of a Nasal Spray on Viral Respiratory Infections

COVID-19 | Common Cold | Acute Respiratory Tract Infection | Flu, Human

France
Sanofi Pasteur, a Sanofi Company

Completed

Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and Adults

Influenza | Swine-Origin A/H1N1 Influenza Virus

France
University Hospital, Strasbourg, France

Unknown

Retrospective Observational Study on the Epidemiological Characteristics of Influenza Patients (Influenza)

Influenza

France
Institut National de la Santé Et de la Recherche...

Completed

"COhort Study on A/H1N1 FLU During PREGnancy" (COFLUPREG)

Pregnancy | Influenza

France
Sanofi Pasteur, a Sanofi Company

Completed

A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly

Influenza | Swine-origin A/H1N1 Influenza

France
ANRS, Emerging Infectious Diseases
P95; I-REIVAC; EPICONCEPT; Institut de Recherche en Santé Publique, France

Recruiting

Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults (RESPIVAC)

COVID-19 | Influenza | Severe Acute Respiratory Infection (SARI)

France
University Hospital, Brest

Completed

National Survey on the Lockdown of Children With Disabilities (ECHO)

Identify Emerging Health Challenges for Children With Motor Disabilities and Their Parents Facing the COVID-19 Pandemic

France
University Hospital, Strasbourg, France

Completed

Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels (COVID-APE)

Covid-19 With Positive RT-PCR

France
Institut National de la Santé Et de la Recherche...
Sanofi

Unknown

Clinical Trial to Assess the Influenza Vaccination (FLUVAC 02) (FLUVAC EV-02)

Adult Hospitalized

France
Sanofi Pasteur, a Sanofi Company

Completed

Study of the Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation (Intradermal Route)

Influenza

France
Hospices Civils de Lyon

Unknown

Nosocomial Influenza Surveillance 2018 - 2022 (NOSOGRIPPE)

Influenza | Hospital-Acquired Infection

France
Hospices Civils de Lyon

Unknown

Immune Response Analysis to Influenza Vaccine in Elderly Aged Over 65 Years (Expand IDWP21)

Immune Response

France
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant Subjects

Influenza | Orthomyxoviridae Infections

France
Centre Hospitalier Universitaire de Nice

Completed

Study of Immune Response During SARS-CoV-2 Infection - (COVID-19) (CovImmune)

New Coronavirus Disease (COVID-19), Infection With SARS-CoV-2

France
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Routes of Immunization and Flu Immune Responses (FLUWAY)

Influenza

France
Assistance Publique - Hôpitaux de Paris

Completed

Vaccination Against Influenza in Autoimmune Diseases (MAIVAX)

Autoimmune Diseases

France
Hospices Civils de Lyon

Completed

Biomarkers for the Prognosis of Influenza in Children (BMIG)

Influenza

France

Clinical Trials on Influenza With Pneumonia in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations